Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 5—May 2015

Transmission of Hepatitis C Virus among Prisoners, Australia, 2005–2012

Neil Arvin Bretaña, Lies Boelen, Rowena Bull, Suzy Teutsch, Peter A. White, Andrew R. Lloyd, Fabio LucianiComments to Author , on behalf of the HITS-p investigators
Author affiliations: The University of New South Wales, Sydney, New South Wales, Australia (N.A. Bretaña, L. Boelen, R. Bull, S. Teutsch, P.A. White, A.R. Lloyd, F. Luciani); Imperial College London, London, UK (L. Boelen)

Main Article

Table 2

Probable HCV transmission events identified by using phylogenetic analysis, spatiotemporal information, and risk behavior information, New South Wales, Australia, 2005–2012*

Cluster Transmission, participant ID no. Period of co-location Prison ID† Patient ID Est. date of infection HCV genotype ATSI Continuously in prison‡ Equipment sharing§ OST§ Heroin use§
A 315 → 117 2007 Dec 31–2008 Jan 22 AT 315 2007 Oct 30 1a No Yes Yes No No
117 2008 Feb 27 1a No No Yes No Yes
315 → 461 2008 Jun 29–Jul 11 AE 315 2007 Oct 30 1a No Yes Yes No No
2008 Sep 24–Oct 1 461 2008 Oct 6 1a No No Yes No Yes
B 304 → 357 2007 Oct 26–Nov 23 AB 304 2007 Apr 17 3a No No No No No
357 2008 Nov 11 3a No Yes Yes No Yes
C 302 → 426 2008 Dec 9–18 AP 302§ 2007 Oct 11 3a Yes No Yes No No
426 2008 Dec 21 3a Yes No Yes Yes No

*All prisoners were injection drug users during the period of co-location. ATSI, Aboriginal and/or Torres Strait Islander descent; est., estimated; HCV, hepatitis C virus; ID, identification; OST, opioid substitution therapy.
†Prisons are identified by codes for de-identification purposes.
‡Continuously in prison 6 mo before estimated date of infection.
§Female patient. All others were male.

Main Article

1Additional HITS-p investigators are listed at the end of this article.

Page created: April 20, 2015
Page updated: April 20, 2015
Page reviewed: April 20, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.